Central regions | Technology & innovation | Finance, business

Skolkovo and AstraZeneca launch medtech start-up acceleration

16 May '19
Russias Skolkovo Foundation and AstraZeneca, a global biopharmaceutical company, are putting together a new joint acceleration program for projects that develop solutions for cancer therapy, cardiovascular diseases, metabolism and kidney problems, and respiratory diseases, Firrma.ru reported.

Primer Capital, a Russian venture fund with international presence, is acting as partner for the acceleration initiative.

The program will be aimed at identifying promising ideas and solutions to benefit the above-mentioned medical fields and also at addressing a range of specific problems in the existing healthcare system. Developing and promoting digital medicine solutions is also a goal for this years acceleration program.
Publish in Twitter
Write to Facebook
Google Buzz
Write to LiveJournal
Show in MM
Share MK
COMMENT ON THIS STORY
Find Related Content

Locations:

Latest News: Central regions
16 Jul '19 | Technology & innovation
12 Jul '19 | Transport, logistics | Technology & innovation
11 Jul '19 | Finance, business | Technology & innovation
10 Jul '19 | Finance, business | Technology & innovation
9 Jul '19 | Finance, business | Technology & innovation
 

Feature stories

26 May '19
This article has been written by Carl Burch, an MBA,...
4 Apr '19
Russian scientists have come up with what they say is...
29 Jan '19
Russian biologists and biophysicists have developed...
Search (News archive - 21382)
Advertising
Venture_Russia_2018
Advertising
NATT
Advertising
Marchmont News

Latest News

16 Jul '19
Researchers at the Moscow State University are...
12 Jul '19
Yandex, a leading Russian IT company, and Hyundai...
11 Jul '19
BI.Zone, a Sberbank asset, is beginning to offer...

Most read stories from last week

16 Jul '19
Researchers at the Moscow State University are...